Resultats globals: 6 registres trobats en 0.02 segons.
Articles, 6 registres trobats
Articles 6 registres trobats  
1.
9 p, 1.1 MB Versatile iron-catechol-based nanoscale coordination polymers with antiretroviral ligand functionalization and their use as efficient carriers in HIV/AIDS therapy / Solórzano Rodríguez, Ruben (Institut Català de Nanociència i Nanotecnologia) ; Tort Regàs, Olívia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Garcia-Pardo, Javier (Institut Català de Nanociència i Nanotecnologia) ; Escribà, Tuixent (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Lorenzo Rivera, Julia (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Arnedo, Mireia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ruiz-Molina, Daniel (Institut Català de Nanociència i Nanotecnologia) ; Alibés Arqués, Ramon (Universitat Autònoma de Barcelona. Departament de Química) ; Busqué Sánchez, Félix (Universitat Autònoma de Barcelona. Departament de Química) ; Novio Vázquez, Fernando (Institut Català de Nanociència i Nanotecnologia)
A novel chemical approach integrating the benefits of nanoparticles with versatility of coordination chemistry is reported herein to increase the effectiveness of well-known HIV antiretroviral drugs. [...]
2019 - 10.1039/c8bm01221k
Biomaterials science, Vol. 7, Issue 1 (January 2019) , p. 178-186  
2.
8 p, 218.5 KB Profile of once-daily darunavir/cobicistat fixed-dose combination for the treatment of HIV/AIDS / Navarro, Jordi (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Curran, Adrian (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
Efficacy is the main objective of antiretroviral treatment and adherence is one of the cornerstones to achieve it. For this reason, treatment simplification is of key importance with regard to antiretroviral regimens. [...]
2016 - 10.2147/HIV.S56158
HIV/AIDS (Auckland, N.Z.), Vol. 8 (october 2016) , p. 175-182  
3.
4 p, 1.4 MB Hidden costs of antiretroviral treatment : the public health efficiency of drug packaging / Andreu-Crespo, Àngels (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Llibre, Josep M (Universitat Autònoma de Barcelona. Departament de Farmacologia, de Terapèutica i de Toxicologia) ; Cardona-Peitx, Glòria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Sala-Piñol, Ferran (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Clotet, Bonaventura (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Bonafont-Pujol, Xavier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
While the overall percentage of unused antiretroviral medicines returned to the hospital pharmacy is low, their cost is quite high. Adverse events, treatment failure, pharmacokinetic interactions, pregnancy, or treatment simplification are common reasons for unplanned treatment changes. [...]
2015 - 10.2147/DDDT.S87075
Drug Design, Development and Therapy, Vol. 9 (august 2015) , p. 4287-4290  
4.
11 p, 203.3 KB Mutations related to Antiretroviral Resistance identified by ultra-deep sequencing in HIV-1 infected children under Structured Interruptions of HAART / Vázquez Guillén, José Manuel (Universidad Autónoma de Nuevo León (Mèxic)) ; Palacios Saucedo, Gerardo C. (Instituto Mexicano del Seguro Social) ; Rivera Morales, Lydia G. (Universidad Autónoma de Nuevo León (Mèxic)) ; García Campos, Jorge (Instituto Mexicano del Seguro Social) ; Ortiz López, Rocío (Universidad Autónoma de Nuevo León (Mèxic)) ; Noguera Julián, Marc (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Paredes, Roger (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Vielma Ramírez, Herlinda J. (Universidad Autónoma de Nuevo León (Mèxic)) ; Ramírez, Teresa (Laboratorio Estatal de Salud Pública del Estado de Nuevo León (Mèxic)) ; Chávez García, Marcelino (Instituto Mexicano del Seguro Social) ; López Guillén, Paulo (Instituto Mexicano del Seguro Social) ; Briones Lara, Evangelina (Instituto Mexicano del Seguro Social) ; Sánchez Sánchez, Luz M. (Instituto Mexicano del Seguro Social) ; Vázquez Martínez, Carlos A. (Instituto Mexicano del Seguro Social) ; Rodríguez Padilla, Cristina (Universidad Autónoma de Nuevo León (Mèxic))
Although Structured Treatment Interruptions (STI) are currently not considered an alternative strategy for antiretroviral treatment, their true benefits and limitations have not been fully established. [...]
2016 - 10.1371/journal.pone.0147591
PloS one, Vol. 11 Núm. 1 (January 2016)  
5.
19 p, 1.2 MB Identification of Immunogenic Cytotoxic T Lymphocyte Epitopes Containing Drug Resistance Mutations in Antiretroviral Treatment-Naïve HIV-Infected Individuals / Blanco Heredia, Juan (Instituto Nacional de Enfermedades Respiratorias (México)) ; Lecanda, Aarón (Instituto Nacional de Enfermedades Respiratorias (México)) ; Valenzuela Ponce, Humberto (Instituto Nacional de Enfermedades Respiratorias (México)) ; Brander Silva, Christian (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Ávila Ríos, Santiago (Instituto Nacional de Enfermedades Respiratorias (México)) ; Reyes Terán, Gustavo (Instituto Nacional de Enfermedades Respiratorias (México))
Background: therapeutic HIV vaccines may prove helpful to intensify antiretroviral treatment (ART) efficacy and may be an integral part of future cure strategies. Methods: we examined IFN-gamma ELISpot responses to a panel of 218 HIV clade B consensus-based HIV protease-reverse transcriptase peptides, designed to mimic previously described and predicted cytotoxic T lymphocyte epitopes overlapping drug resistance (DR) positions, that either included the consensus sequence or the DR variant sequence, in 49 ART-naïve HIV-infected individuals. [...]
2016 - 10.1371/journal.pone.0147571
PloS one, Vol. 11 Núm. 1 (January 2016)  
6.
19 p, 76.2 KB Interruptions of antiretroviral therapy in human immunodeficiency virus infection : are they detrimental to neurocognitive functioning? / Muñoz-Moreno, Jose Antonio (Institut Germans Trias i Pujol. Institut de Recerca de la Sida IrsiCaixa) ; Fumaz, Carmina R. (Rodríguez Fumaz) (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Prats, Anna (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Ferrer, Maria J. (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Negredo Puigmal, Eugènia (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Pérez-Álvarez, Núria (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Moltó, José (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Gómez Melis, Guadalupe (Universitat Politècnica de Catalunya) ; Garolera i Freixa, Maite (Consorci Sanitari Hospital de Terrassa) ; Clotet, Bonaventura (Institut Germans Trias i Pujol. Fundació de Lluita Contra la Sida) ; Universitat Autònoma de Barcelona
Background: Since interruptions of antiretroviral treatment may entail clinical risks for HIV-infected individuals, we investigated their impact on neurocognitive functioning. Methods: Cross-sectional study comparing HIV-infected persons who had interrupted antiretroviral therapy in the past (interruption group, IG) with persons who had never discontinued therapy (non-interruption group, NIG). [...]
2010
Journal of Neurovirology, Vol. 16, Issue 3 (May 2010) , p. 208-218
6 documents

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.